Risk factor
Very high price volatility
Profitability factor
Very low or no dividends
About
Merchavia Holdings and Investments Ltd., founded in 1972 and based in Bnei Brak, Israel, operates as an investment company with a primary focus on the Israeli life sciences industry. Its varied portfolio includes funding and developing numerous cutting-edge medical and healthcare solutions. The company's ventures cover: Innovative diagnostic tools aimed at detecting cancer. Wearable medical equipment, such as smartwatches, bracelets, and patches, equipped with sensor technology for health monitoring and diagnostic purposes. Aura smart air, an intelligent, data-driven system that uses user behavior algorithms and real-time smart sensors to oversee and manage both indoor and outdoor air quality. TrainPain, a digital therapeutic designed to enhance the mental and emotional health of individuals suffering from neuropathic and fibromyalgia pain. RevDx (Revolutionary Diagnostics), a compact, handheld device enabling immediate complete blood count analyses. A rechargeable electric cannabis inhaler, which connects via Bluetooth to the VEOLI App for managing dosages and capsule supply. An artificial intelligence-driven neuromonitoring instrument intended for use in operating rooms to prevent nerve damage during surgery. Additionally, Merchavia is engaged in the creation, manufacturing, and commercialization of women's health products. Notable offerings include Ballerine, a copper-based, hormone-free intrauterine contraceptive device, and a spherical endometrial ablation device currently undergoing Phase IIa clinical trials for treating abnormal uterine bleeding. The company was formerly known as Nepco Star Ltd. until its name officially changed to Merchavia Holdings and Investments Ltd. in November 2014.
Company Valuation
Based on key historical and expected multiples, the stock is slightly undervalued relative to its peers.